Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Abstract
It is generally thought that many drug molecules are transported across biological membranes via passive diffusion at a rate related to their lipophilicity. However, the types of biophysical forces involved in the interaction of drugs with lipid membranes are no different from those involved in their interaction with proteins, and so arguments based on lipophilicity could also be applied to drug uptake by membrane transporters or carriers. In this article, we discuss the evidence supporting the idea that rather than being an exception, carrier-mediated and active uptake of drugs may be more common than is usually assumed - including a summary of specific cases in which drugs are known to be taken up into cells via defined carriers - and consider the implications for drug discovery and development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Note that despite a widespread assumption that lipophilicity or log P is sufficient to account for drug distribution this is not in fact the case, as there are hundreds of natural transporters that drugs can use (e.g. [18,1714]).”
In the citing paper
“(Note that liophilicity per se may not be relevant, as drugs require carriers to cross membranes [18], and promiscuity and off-target effects increase with lipophilicity [1679].)”
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
CHEMIOSMOTIC COUPLING IN OXIDATIVE AND PHOTOSYNTHETIC PHOSPHORYLATION
MITCHELL, P. (1966) · Biological Reviews · doi:10.1111/j.1469-185x.1966.tb01501.x · Cited by 3,663
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Hucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg015 · Cited by 3,060
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512 · cited 1×
“, do not obey the Ro5 (for example, most antibacterial”
BackgroundThe influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403 · cited 1×
“This is because many of the recent trends in molecular drug design and development have been towards increased lipophilicity, leading to a greater likelihood of both a lack of selectivity and of attritio”
BackgroundThe Membrane Actions of Anesthetics and Tranquilizers
Seeman, P. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06931-5 · Cited by 2,246
Abraham, M. H. (1993) · Chemical Society Reviews · doi:10.1039/cs9932200073 · Cited by 1,968
Osmotic Stress Signaling and Osmoadaptation in Yeasts
Hohmann, S. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.2.300-372.2002 · Cited by 1,767
Research works printed but not linked: 1
- Jain, M. K. The Bimolecular Lipid Membrane. (Van Nostrand Reinhold, New York, 1972).
Cited by
Items 201–300 of 479
Harikrishnan, S., Sedev, R. V., Beh, C. C., Priest, C., & Foster, N. R. (2020) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2020.104756 · Cited by 34
Kang, J. Y., Kim, S., Kim, J., Kang, N., Yang, C., Min, S., & Kim, J. W. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01940b · Cited by 34
Membrane transporter identification and modulation via adaptive laboratory evolution
Radi, M. S., Salcedo-Sora, J. E., Kim, S. H., Sudarsan, S., Sastry, A. V., Kell, D. B., Herrgård, M. J., & Feist, A. M. (2022) · Metabolic Engineering · doi:10.1016/j.ymben.2022.05.004 · Cited by 37
Self-citationPhysicochemical profile of macrolides and their comparison with small molecules
Stepanić, V., Žiher, D., Gabelica, V., Jelić, D., Nunhuck, S., Valko, K. L., & Koštrun, S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.11.016 · Cited by 35
Accurate Prediction of Ligand Affinities for a Proton-Dependent Oligopeptide Transporter
Samsudin, F., Parker, J. L., Sansom, M. S. P., Newstead, S. L., & Fowler, P. W. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2015.11.015 · Cited by 34
“…in the epithelia of the intestine, kidney, and liver, and in the endothelia of the blood-brain barrier influence not only drug absorption and distribution (Dobson and Kell, 2008) but also their therapeutic efficacy and potential adverse reactions (Shitara and Sugiyama, 2002; Cusatis et al., 2006).”
BackgroundExploiting the therapeutic potential of Plasmodium falciparum solute transporters
Staines, H. M., Derbyshire, E. T., Slavić, K., Tattersall, A. L., Vial, H. J., & Krishna, S. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2010.03.004 · Cited by 33
Luo, H., Lu, L., Liu, N., Li, Q., Yang, X., & Zhang, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00966-6 · Cited by 33
“However, the fluorescence signal of free Cur in 5-8F cells was weak and located on the surface of the cell membrane, consistent with previous reports that small molecular Cur enters cells via passive diffusion [26].”
ResultFujiwara, K., Yoshizaki, Y., Shin, M., Miyazaki, T., Saita, T., & Nagata, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01267-12 · Cited by 33
“crovilli may also suggest the occurrence of an unknown transporter(s) for VM at the brush border of the proximal tubules in the kidney, as the sites are known to be where a variety of transport systems in drug interactions occur (6, 22, 28, 38, 45, 47, 48).”
BackgroundHost cell environments and antibiotic efficacy in tuberculosis
Day, N. J., Santucci, P., & Gutierrez, M. G. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.08.009 · Cited by 40
Yee, S. W., Macdonald, C. B., Mitrovic, D., Zhou, X., Koleske, M. L., Yang, J., Buitrago Silva, D., Rockefeller Grimes, P., Trinidad, D. D., More, S. S., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.04.008 · Cited by 31
Zuo, H., Guo, L., Li, Q., Guo, X., Wu, Q., Li, H., Kang, Z., Ma, W., Wang, S., Jiao, L., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00894 · Cited by 35
Primary hepatocyte cultures as prominentin vitrotools to study hepatic drug transporters
Ramboer, E., Vanhaecke, T., Rogiers, V., & Vinken, M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.756010 · Cited by 34
Broberg, M. L., Holm, R., Tønsberg, H., Frølund, S. U., Ewon, K., Nielsen, A. T., Brodin, B., Jensen, A., Kall, M., Christensen, K. V., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02030.x · Cited by 36
“Membrane transporters in the gastrointestinal tract (GIT) are increasingly being recognized as important for drug absorption and hence for the overall pharmacokinetic profile of drug substances (Dobson and Kell, 2008; Giacomini et al., 2010; Sugano et al., 2010).”
BackgroundZheng, Y., Benet, L. Z., Okochi, H., & Chen, X. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1640-3 · Cited by 35
“text: BCarrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?^ [17]; BImplications”
Use of the Øie-Tozer Model in Understanding Mechanisms and Determinants of Drug Distribution
Waters, N. J., & Lombardo, F. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032458 · Cited by 37
“In addition, Dobson and Kell (2008) concluded that active transport processes are fundamental in determining drug disposition and are probably more common than usually assumed, citing the mounting evidence in the literature on specific drug examples as well as observations that drugs can concentrate in specific tissue…”
BackgroundFitting Transporter Activities to Cellular Drug Concentrations and Fluxes: Why the Bumblebee Can Fly
Mendes, P., Oliver, S. G., & Kell, D. B. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.07.006 · Cited by 30
“We already gave many hundreds of examples [1].”
BackgroundSelf-citationLumen, A., Li, L., Li, J., Ahmed, Z., Meng, Z., Owen, A. J., Ellens, H. M., Hidalgo, I. J., & Bentz, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069394 · Cited by 32
“sion on the relative importance of transporters and passive permeability in transport biology [31][32][33][34].”
Fang, S., Hou, Y., Ling, L., Wang, D., Ismail, M., Du, Y., Zhang, Y., Yao, C., & Li, X. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.02.046 · Cited by 34
Fundamental physical and chemical concepts behind “drug-likeness” and “natural product-likeness”
Athar, M., Sona, A. N., Bekono, B. D., & Ntie‐Kang, F. (2019) · Physical Sciences Reviews · doi:10.1515/psr-2018-0101 · Cited by 39
“– carrier-mediated active transporters in the cell membrane easily facilitate the absorption of several molecules that could fail the “drug-likeness” test as defined by simple rule of the thumbs, typically NPs [14], which were excluded from such a definition”
BackgroundFouché, M., Schaefer, M., Blatter, M., Berghausen, J., Desrayaud, S., & ROTH, H. ‐. (2016) · ChemMedChem · doi:10.1002/cmdc.201600083 · Cited by 31
Contribution of tumoral and host solute carriers to clinical drug response
Sprowl, J. A., Mikkelsen, T. S., Giovinazzo, H., & Sparreboom, A. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.009 · Cited by 33
“Perhaps the largest contributing factor to the apparent historic lack of interest in solute carrier research is the long-held belief that most xenobiotics are transported across membranes via passive diffusion at a rate related to their hydrophobicity (Dobson and Kell, 2008).”
BackgroundO’Hagan, S., & Kell, D. B. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00266 · Cited by 29
“As part of a series of studies of the transporter-mediated uptake of pharmaceutical drugs into biological cells (e.g., Dobson and Kell, 2008; Dobson P. et al., 2009; Kell and Dobson, 2009; Kell et al., 2011, 2013, 2015; Lanthaler et al., 2011; Kell, 2013, 2015a,b, 2016a,b; Kell and Goodacre, 2014;…”
BackgroundSelf-citationHuttunen, J., Gynther, M., Vellonen, K., & Huttunen, K. M. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118714 · Cited by 30
Gut Microbiome: A New Organ System in Body
Anwar, H., Irfan, S., Hussain, G., Faisal, M. N., Muzaffar, H., Mustafa, I., Mukhtar, I., Malik, S., & Ullah, M. I. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.89634 · Cited by 42
Diffusion of small molecule drugs is affected by surface interactions and crowder proteins
Dey, D., Nunes‐Alves, A., Wade, R. C., & Schreiber, G. (2022) · iScience · doi:10.1016/j.isci.2022.105088 · Cited by 30
“However, more recently carrier-mediated transport (Dobson and Kell, 2008; Di et al., 2012) or a combination of the two were also identified (Sugano et al.”
Kell, D. B., & Dobson, P. D. (2009) · Research Explorer (The University of Manchester) · Cited by 31
Self-citationPisco, A. O., Jackson, D. A., & Huang, S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00306 · Cited by 30
“Recent reports suggest that all cellular transport might be in some way carrier-mediated and that passive diffusion is negligible (34, 41, 42).”
BackgroundWeddell, J. C., & Imoukhuede, P. I. (2017) · Integrative Biology · doi:10.1039/c7ib00011a · Cited by 37
Basic Nitrogen (BaN) Is a Key Property of Antimalarial Chemical Space
Valluri, H., Bhanot, A., Shah, S., Bhandaru, N., & Sundriyal, S. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00206 · Cited by 31
O’Hagan, S., & Kell, D. B. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0198-y · Cited by 29
Self-citationThe contribution of physicochemical properties to multiple in vitro cytotoxicity endpoints
Lu, S., Jessen, B. A., Strock, C., & Will, Y. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.01.025 · Cited by 28
Rosa-Fernandes, L., Stern, A. C. B., Cavaglieri, R. D. C., Nogueira, F. C. S., Domont, G. B., Palmisano, G., & Bydlowski, S. P. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.06.011 · Cited by 28
O’Hagan, S., & Kell, D. B. (2017) · Biotechnology Journal · doi:10.1002/biot.201700503 · Cited by 30
Self-citationUltrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells
Bjånes, T. K., Kotopoulis, S., Murvold, E. T., Kamčeva, T., Gjertsen, B. T., Gilja, O. H., Schjøtt, J. D., Riedel, B., & McCormack, E. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020141 · Cited by 29
Hadden, M., Goodman, A., Guo, C., Guzzo, P. R., Henderson, A. J., Pattamana, K., Ruenz, M. M., Sargent, B. J., Swenson, B., Yet, L., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.028 · Cited by 27
Bayesian inference of the sites of perturbations in metabolic pathways via Markov chain Monte Carlo
Jayawardhana, B., Kell, D. B., & Rattray, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn103 · Cited by 26
“Drug discovery is now recognized as a problem of integrative systems biology requiring genome-wide analyses (see, e.g. Butcher, 2005; Dobson and Kell, 2008; Williams, 2005).”
BackgroundSelf-citationSalcedo-Sora, J. E., Jindal, S., O’Hagan, S., & Kell, D. B. (2021) · Microbiology · doi:10.1099/mic.0.001016 · Cited by 26
“…harbouring single-gene knockouts, consistent with the views that (i) any electron transport-mediated membrane potential was not largely responsible for their steady-state uptake [23–25], and (ii) any non- transporter-mediated transport through the phospholipid bilayer was negligible [26–31].”
Self-citationOja, M., & Maran, U. (2015) · Molecular Informatics · doi:10.1002/minf.201400147 · Cited by 26
Grixti, J. M., O’Hagan, S., Day, P. J., & Kell, D. B. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00155 · Cited by 27
“…abundant evidence that the non-transporter- (i.e., bilayer-) mediated uptake of drugs through intact cell membranes is normally negligible (e.g., Dobson and Kell, 2008; Dobson et al., 2009a,b; Kell et al., 2011, 2013, 2015; Lanthaler et al., 2011; Kell, 2013, 2015a,b, 2016a,b; Kell and…”
BackgroundSelf-citationDumond, J., Adams, J. F., Prince, H., Kendrick, R., Wang, R., Jennings, S., Malone, S., White, N., Sykes, C., Corbett, A., et al. (2013) · HIV Medicine · doi:10.1111/hiv.12017 · Cited by 33
“Both drugs are substrates for drug transporters (31), and the potential effects of aging on drug transport activity has not been well categorized (32).”
BackgroundToday’s drug discovery and the shadow of the rule of 5
Young, R. J. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2228199 · Cited by 30
van Hell, A. J., Melo, M. N., BLITTERSWIJK, W. J. V., Gueth, D. M., Braumuller, T. M., Pedrosa, L. R. C., Song, J., Marrink, . J., Koning, G. A., Jonkers, J., et al. (2013) · Scientific Reports · doi:10.1038/srep01949 · Cited by 25
The Flip-Flop Diffusion Mechanism across Lipids in a Hybrid Bilayer Membrane
Barile, C. J., Tse, E. C. M., Li, Y., Gewargis, J. P., Kirchschlager, N. A., Zimmerman, S. C., & Gewirth, A. A. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.04.041 · Cited by 27
Sepay, N., Guha, C., Maity, S., & Mallik, A. K. (2017) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201701224 · Cited by 25
Transporter effects on cell permeability in drug delivery
Mandal, A., Agrahari, V., Khurana, V., Pal, D., & Mitra, A. K. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1214565 · Cited by 25
Chernenko, T., Buyukozturk, F., Miljkovic, M., Carrier, R., Diem, M., & Amiji, M. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0178-3 · Cited by 24
Tatsumi, S., Matsuoka, H., Hashimoto, Y., Hatta, K., Maeda, K., & Kamoshida, S. (2014) · Europe PMC (PubMed Central) · Cited by 24
Experimental determination and prediction of bilitranslocase transport activity
Župerl, Š., Fornasaro, S., Novič, M., & Passamonti, S. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.07.004 · Cited by 25
Bieczynski, F., Burkhardt‐Medicke, K., Luquet, C. M., Scholz, S., & Luckenbach, T. (2020) · FEBS Letters · doi:10.1002/1873-3468.14015 · Cited by 23
Do Biologically Relevant Compounds Have More Chance To Be Drugs?
De, K., Ren, W., Lu, W. P., & Zhang, H. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900229c · Cited by 24
Ghosh, A., Maurer, T. S., Litchfield, J., Varma, M. V., Rotter, C. J., Scialis, R. J., Feng, B., Tu, M., Guimarães, C. R. W., & Scott, D. O. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058032 · Cited by 24
“The translatability in passive permeability parameters between HEK-293 cells and MDCK-LE cells is at odds with recent speculation that passive permeation is a transporter-mediated phenomenon (Dobson and Kell, 2008; Kell et al., 2011).”
BackgroundIn silico Prioritization of Transporter–Drug Relationships From Drug Sensitivity Screens
César‐Razquin, A., Girardi, E., Yang, M., Brehme, M., Sáez-Rodríguez, J., & Superti‐Furga, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01011 · Cited by 24
Ta, G. H., Jhang, C.-S., Weng, C., & Leong, M. K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020174 · Cited by 27
Velický, M., Tam, K. Y., & Dryfe, R. A. W. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.08.007 · Cited by 24
“norfloxacin, gatifloxacin) or anion (cefixime) may be enhanced by active processes via organic anion transporter proteins (Dobson and Kell, 2008).”
BackgroundResultIslam, M. N., Islam, M. S., Hoque, M. A., Kato, T., Nishino, N., Ito, A., & Yoshida, M. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.06.031 · Cited by 23
Liu, Y., Rohrs, J. A., & Wang, P. (2015) · Current Drug Metabolism · doi:10.2174/1389200216666150223152958 · Cited by 23
“P-gp [37, 84-86].”
Celli, G. B., Ghanem, A., & Brooks, M. S. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1104290 · Cited by 24
Marhadour, S., Wu, H., Yang, W., Marivingt‐Mounir, C., Bonnemain, J., & Chollet, J. (2017) · Pest Management Science · doi:10.1002/ps.4575 · Cited by 23
“Experimental procedure for the synthesis of 4-azido-2-[(tert-butoxycarbonyl)amino]butanoic acid (7) and 6-azido-2-[(tert-butoxycarbonyl)amino]hexanoic acid (8) To a solution of sodium azide (6.”
MethodChang, E. D., Högstrand, C., Miller, T. H., Owen, S. F., & Bury, N. R. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.8b04394 · Cited by 23
Li, H., Li, Q., Guo, L., Guo, X., Zhang, Q., Wang, Z., Wu, Q., Wang, S., Jiao, L., & Hao, E. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c09606 · Cited by 25
Higueruelo, A. P., Schreyer, A. M., Bickerton, G. R., Blundell, T. L., & Pitt, W. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051742 · Cited by 22
“For oral drugs, lipophilicity is generally considered a requirement for their absorption by passive diffusion in membranes, although there is some debate regarding the contribution of carrier-mediated transport to cellular uptake [6,7].”
Review of the pharmacokinetics of French maritime pine bark extract (Pycnogenol®) in humans
Bayer, J., & Högger, P. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1389422 · Cited by 28
Kell, D. B. (2015) · Perspectives in Science · doi:10.1016/j.pisc.2015.06.004 · Cited by 23
Self-citationO’Connor, I. A., Huijbregts, M. A. J., Ragas, A. M. J., & Hendriks, A. J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.10.015 · Cited by 22
“However, the compounds contained in the data set still might be transferred by other processes such as paracellular transport, active transport or lipid digestion mechanisms (Dobson and Kell, 2008; Fischer et al., 2005; Kansy et al., 1998; Kelly et al., 2004; Lennernas, 1995).”
BackgroundCabrera‐Pérez, M. Á., Sanz, M. B., Sanjuan, V. M., González‐Álvarez, M., & González‐Álvarez, I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-100094-6.00002-x · Cited by 24
Bąk, K. M., van Kolck, B., Maslowska-Jarzyna, K., Papadopoulou, P., Kros, A., & Chmielewski, M. J. (2020) · Chemical Communications · doi:10.1039/c9cc09888g · Cited by 22
Žiberna, L., Fornasaro, S., Čvorović, J., Tramer, F., & Passamonti, S. (2013) · Polyphenols in Human Health and Disease · doi:10.1016/b978-0-12-398456-2.00037-2 · Cited by 28
Jensen, K., Plichta, D. R., Panagiotou, G., & Kouskoumvekaki, I. A. (2012) · Molecular BioSystems · doi:10.1039/c2mb00008c · Cited by 21
Batta, G., Kárpáti, L., Henrique, G. F., Tóth, G., Tarapcsák, S., Kovács, T., Zákány, F., Mándity, I. M., & Nagy, P. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15509 · Cited by 23
“Organic anion transporter polypeptides (OATP) have been implicated in transmembrane import of statins (Dobson & Kell, 2008).”
BackgroundOlszewski, U., Svoboda, M., Thalhammer, T., Buxhofer‐Ausch, V., Geissler, K. H., & Hamilton, G. (2011) · Biomarkers in Cancer · doi:10.4137/bic.s7151 · Cited by 21
Use of imaging to assess the activity of hepatic transporters
Hernández-Lozano, I., & Langer, O. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1718107 · Cited by 22
“There is an increasing awareness that drug molecules most often do not cross biological membranes by simple passive diffusion, but require the presence of carrier-mediated processes [1,2].”
BackgroundPersistent glucose consumption under antibiotic treatment protects bacterial community
Zhang, Y., Cai, Y., Jin, X., Wu, Q., Bai, F., & Liu, J. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01708-z · Cited by 19
“The accumulation of many antibiotics depends on bacterial membrane potential 42–44 .”
Fujiwara, K., Shin, M., Miyazaki, T., & Maruta, Y. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01031-10 · Cited by 20
“In the last decade, numerous studies concerning either the uptake or the elimination of -lactam antibiotics have been undertaken using as models in vitro-isolated hepatocytes, Xenopus oocytes, and renal cell lines expressing carrier-mediated transporters (10, 23, 50).”
BackgroundStructural Analysis of a Peptide Fragment of Transmembrane Transporter Protein Bilitranslocase
Perdih, A., Choudhury, A. R., Župerl, Š., Sikorska, E., Zhukov, I., Šolmajer, T., & Novič, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038967 · Cited by 22
“Therefore, it is also likely to be involved in the drug uptake, since carriermediated and active uptake of pharmaceutical drugs may be more common than is usually assumed, and should be considered as an essential step in rational drug discovery and development as reviewed in a recent perspective by Dobson and Kell [14…”
BackgroundHow Physicochemical Properties of Drugs Affect Their Metabolism and Clearance
Karlgren, M., & Bergström, C. A. S. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622376-00001 · Cited by 22
Kamoshida, S. (2013) · Molecular and Clinical Oncology · doi:10.3892/mco.2013.104 · Cited by 19
Tang, J., Xie, D., Yin, H., Jing, J., & Zhang, J. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00249h · Cited by 19
Ogane, N., Yasuda, M., Kameda, Y., Yokose, T., Kato, H., Itoh, A., Nishino, S., Hashimoto, Y., & Kamoshida, S. (2013) · Biomedical Research · doi:10.2220/biomedres.34.143 · Cited by 19
“Anticancer agents require transporter-mediated uptake to efficiently enter cancer cells and access their intracellular targets (5).”
InfluentialMarcondes, M. C., Fernandes, A. C. S., Itabaiana, I., de Souza, R. O. M. A., Sola‐Penna, M., & Zancan, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130555 · Cited by 20
“This facilitated transmembrane drug transport would be more efficient for more media-soluble drugs [49,50].”
BackgroundOn the structure and stability of novel cationic DPPC liposomes doped with gemini surfactants
Domínguez-Arca, V., Sabín, J., García‐Río, L., Bastos, M., Taboada, P., Barbosa, S., & Prieto, G. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.120230 · Cited by 18
“The differences about these gel conformations may play a crucial role in membrane permeability [68].”
Chiral Transport in Nanochannel Based Artificial Drug Transporters
Yang, L., Sun, Z. J., Zhang, S., Sun, Y. M., & Li, H. (2022) · Small · doi:10.1002/smll.202205274 · Cited by 18
Özvegy‐Laczka, C., Ungvári, O., & Bakos, É. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115448 · Cited by 18
Horváth, G., Mendes, E. S., Schmid, N., Schmid, A., Conner, G. E., Fregien, N. L., Salathe, M. A., & Wanner, A. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2011.08.002 · Cited by 18
“However, their roles in airway drug absorption and elimination have not been fully elucidated [21].”
BackgroundThe Discovery of Navitoclax, a Bcl-2 Family Inhibitor
Wendt, M. D. (2012) · Topics in medicinal chemistry · doi:10.1007/978-3-642-28965-1_7 · Cited by 18
Kiriakidi, S., Chatzigiannis, C., Papaemmanouil, C. D., Tzakos, A. G., & Mavromoustakos, T. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.183142 · Cited by 22
Predictive approaches to increase absorption of compounds during lead optimisation
Valko, K. L., Butler, J., & Eddershaw, P. J. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.815613 · Cited by 20
“Although this view is still the subject of some controversy [51,52] it is likely that the properties thought to favour passive membrane permeability show considerable overlap with those necessary for transporter-mediated uptake and efflux and that this understanding offers the opportunity for further refinement of our…”
BackgroundMultidrug Resistance Proteins of the ABCC Subfamily
Nies, A. T., & Lang, T. (2014) · Wiley eBooks · doi:10.1002/9781118705308.ch10 · Cited by 19
Kell, D. B., Pretorius, E., & Zhao, H. (2025) · Pharmaceuticals · doi:10.3390/ph18050712 · Cited by 18
Self-citationBhanot, A., & Sundriyal, S. (2021) · ACS Omega · doi:10.1021/acsomega.1c00104 · Cited by 18
Membrane Transporters Involved in the Antimicrobial Activities of Pyrithione in Escherichia coli
Salcedo-Sora, J. E., Robison, A. T. R., Zaengle-Barone, J. M., Franz, K. J., & Kell, D. B. (2021) · Molecules · doi:10.3390/molecules26195826 · Cited by 18
Self-citationWilson, D. M., Driedger, D., Liu, D. Y., Keerthisinghe, S., Hermann, A., Bieniossek, C., Linington, R. G., & Britton, R. (2024) · Nature Communications · doi:10.1038/s41467-024-46721-x · Cited by 17
“Macrocycles along with many other natural products may also bene fi t from active transport mechanisms 8 .”
BackgroundEnvironmental Comparative Pharmacology: Theory and Application
Gunnarsson, L. M., Kristiansson, E., & Larsson, D. G. J. (2012) · Emerging topics in ecotoxicology · doi:10.1007/978-1-4614-3473-3_5 · Cited by 19
Min, K. A., Rosania, G. R., Kim, C., & Shin, M. C. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0704-6 · Cited by 22
“This finding on the differences in transport/retention of fluorescent molecules in airway cell types might be related to different expression levels of cellular components involved in drug accumulation or uptake mechanism (Casartelli et al. 2003; Dobson and Kell 2008).”
BackgroundRole of membrane transporters in the safety profile of drugs
Lee, E. J. D., Lean, C. B., & Limenta, L. M. G. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903176421 · Cited by 19
“(2009) 5(11) data shows a lack of correlation between either uptake of a range of drugs into human cells and the diffusion across artificial membranes, or the hydrophobicity of the molecule, log K [17].”
BackgroundInfluentialShimakata, T., Kamoshida, S., Kawamura, J., Ogane, N., Kameda, Y., Yanagita, E., Itoh, T., Takeda, R., Naka, A., Sakamaki, K., et al. (2016) · Histopathology · doi:10.1111/his.13004 · Cited by 16
“The cytotoxicity of anticancer drugs is related directly to how much drug enters a cancer cell and accesses intracellular targets.(7,8) Indeed, the influx of drug molecules via solute carrier (SLC) transporters is an important determinant of intracellular drug concentrations, and a high level of SLC transporter uptake…”
BackgroundDolberg, A. M., & Reichl, S. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.07.040 · Cited by 17
Kell, D. B. (2021) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2021.01.001 · Cited by 16
Self-citationUlmschneider, M. B., & Searson, P. C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.026 · Cited by 17
Understanding transport through pharmacological barriers — are we there yet?
Sarkadi, B., & Szakács, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187-c1 · Cited by 16
Brenner, S., Riha, J., Giessrigl, B., Thalhammer, T., Grusch, M., Krupitza, G., Stieger, B., & Jäger, W. R. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2731 · Cited by 15
Metadata
- Authors
- Dobson, P. D., & Kell, D. B.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Kell, Douglas B.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-03
- Volume
- 7
- Issue
- 3
- Pages
- 205-220
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2157619122
- Cited by
- 475
- References
- 265
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 20 · 2023: 19 · 2022: 18 · 2021: 24 · 2020: 27 · 2019: 20 · 2018: 17 · 2017: 28 · 2016: 36 · 2015: 43 · 2014: 42 · 2013: 29 · 2012: 36
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- Royal Society
- Wolfson Foundation
- Engineering and Physical Sciences Research Council
- Biotechnology and Biological Sciences Research Council (747/1, BB/D007)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- passive diffusion, lipophilicity, membrane transporters, drug discovery, drug development
- MeSH terms
- Animals, Biological Transport, Cell Membrane, Cell Membrane Permeability, Pharmaceutical Preparations, Humans, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.